| Literature DB >> 33283001 |
Erica R Blanchard1, Christopher J Hadley2, Eric D Wicks3, William Emper2, Steven B Cohen2.
Abstract
BACKGROUND: Meniscal tears are a common knee injury. Isolated meniscal tears are less common; however, unaddressed tears can be troublesome, particularly for athletes. There is currently a lack of data in the literature on athletes returning to play after isolated meniscal repair.Entities:
Keywords: isolated meniscal repair; meniscal tear; return to play
Year: 2020 PMID: 33283001 PMCID: PMC7686632 DOI: 10.1177/2325967120962093
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) chart outlining the review of articles from the search.
Study Characteristics
| Study | Study Design | No. of Patients (M/F) | Mean Age, y (range) | Mean Follow-up, mo (range) | Surgical Technique |
|---|---|---|---|---|---|
| Alpar (1991)[ | Prospective | 50 (48/2) | 26 (21-25) | 38 (24-60) | Open |
| Alvarez-Diaz (2016)[ | CS | 14 (NR) | 27 (18-37) | 72 (60-96) | All inside |
| Bizzini (2006)[ | CR | 1 (1/—) | 30 (NR) | 60 (NR) | Inside-out |
| Cassidy (1981)[ | Prospective | 27 (20/7) | 18 (13-34) | 11 (6-17) | Open |
| Garofalo (2005)[ | CR | 1 (1/—) | 19 (NR) | 12 (NR) | Inside-out |
| Griffin (2015)[ | Retrospective | 9 | 35 (19-68) | 48 (24-72) | Arthroscopic |
| Haklar (2008)[ | Prospective | 5 (NR) | 28.6 (17-35) | 31 (12-36) | Inside-out |
| Hetsroni (2011)[ | CS | 5 (—/5) | 16.2 (14-18) | 31 (15-38) | All-inside |
| Krych (2008)[ | CS | 44 (38/6) | 15.8 (9.9-18.7) | 69.6 (2.5-165.6) | Arthroscopic mix |
| Maruyama (1996)[ | CR | 1 (—/1) | 16 (NR) | 20 (NR) | All-inside |
| Marzo (2007)[ | CR | 1 (1/—) | 17 (NR) | 14 (NR) | Arthroscopic |
| Nakayama (2017)[ | CS | 46 (34/12) | 22.9 (12-50) | 19.8 (12-33) | Inside-out |
| Pabian (2008)[ | CR | 1 (1/—) | 17 (NR) | 10 (NR) | Arthroscopic |
| Papachristou (2003)[ | Prospective | 25 (17/8) | 21 (16-27) | 36 (9-54) | Mix: open and inside-out |
| Park (2012)[ | CR | 1 (1/—) | 19 (NR) | NR | All-inside |
| Pujol (2013)[ | Retrospective | 28 (22/6) | 25 (16-44) | 40 (24-101) | Open |
| Sallé de Chou (2015)[ | |||||
| Group 1 | Retrospective | 24 (18/6) | 27 (13-40) | 15 (12-45) | Mix: open and all-inside |
| Group 2 | Retrospective | 10 (7/3) | 24 (14-45) | 120 (97-142) | Mix: open and all-inside |
| Sonnery-Cottet (2013)[ | CR | 1 (1/0) | 15 (NR) | NR | All-inside hybrid |
| Stein (2009)[ | Retrospective | 15 (10/5) | 31.3 (20-63) | 29.9 (20.3-70) | Inside-out |
| Stein (2010)[ | Retrospective | 42 (26/16) | 31.5 (NR) | 105.6 (NR) | Inside-out |
| Vanderhave (2011)[ | Retrospective | 18 (NR) | 13.2 (9-17) | 27 (17-52) | Inside-out |
| Average (range) | — | — | 22.5 (9-68) | 8.7 (2.5-165.5) | — |
CR, case report; CS, case series; NR, not reported. Dash implies where the average cannot be calculated.
Summary of Outcomes
| Study | No. of Patients | No. to Return to Play | Return to Play Time, mo |
|---|---|---|---|
| Alpar (1991)[ | 50 | 20 | 8 |
| Alvarez-Diaz (2016)[ | 14 | 13 | 4.3 |
| Bizzini (2006)[ | 1 | 1 | 3.4 |
| Cassidy (1981)[ | 27 | 25 | 6 |
| Garofalo (2005)[ | 1 | 1 | 4 |
| Griffin (2015)[ | 9 | 7 | NR |
| Haklar (2008)[ | 5 | 5 | 4.5 |
| Hetsroni (2011)[ | 5 | 5 | NR |
| Krych (2008)[ | 44 | 43 | 5 |
| Maruyama (1996)[ | 1 | 1 | 20 |
| Marzo (2007)[ | 1 | 1 | 5 |
| Nakayama (2017)[ | 46 | 37 | 6.2 |
| Pabian (2008)[ | 1 | 1 | 5 |
| Papachristou (2003)[ | 25 | 15 | NR |
| Park (2012)[ | 1 | 1 | 6 |
| Pujol (2013)[ | 21 | 20 | 10 |
| Sallé de Chou (2015)[ | |||
| Group 1 | 18 | 16 | NR |
| Group 2 | 9 | 9 | 24 |
| Sonnery-Cottet (2013)[ | 1 | 1 | 5 |
| Stein (2009)[ | 15 | 15 | 30 |
| Stein (2010)[ | 42 | 40 | NR |
| Vanderhave (2011)[ | 18 | 18 | 5.6 |
| Total or mean (range) | 355 | 295 | 8.7 (3.5-30) |
NR, not reported.
Of the 28 patients, 21 were contacted on follow-up.
Of the 24 patients, 18 were contacted on follow-up.
Of the 10 patients, 9 were contacted on follow-up.
Subjective Outcome Scores
| Study | Tegner Score | Lysholm Score | IKDC Score | KOOS |
|---|---|---|---|---|
| Alvarez-Diaz (2016)[ | 6 | — | — | — |
| Griffin (2015)[ | — | 89 | 76 | — |
| Haklar (2008)[ | — | 94.2 | — | — |
| Hetsroni (2011)[ | 7 | — | 87 | — |
| Krych (2008)[ | 8 | — | 89.4 | — |
| Nakayama (2017)[ | 6.4 | 97.2 | — | — |
| Papachristou (2003)[ | Range, 6-7 | — | — | — |
| Pujol (2013)[ | — | — | 89 | 78 |
| Sallé de Chou (2015)[ | — | Group 1: 90 | Group 1: 85 | Group 1: 87 |
| Stein (2009)[ | 5.9 | 95.5 | — | — |
| Stein (2010)[ | 5.46 | 91.54 | — | — |
| Vanderhave (2011)[ | 8 | — | — | — |
| Mean (range) | 6.68 (5.46-8) | 93.9 (89.0-99.6) | 86.3 (76-91.2) | 84.4 (78-88.3) |
Outcome scores were reported at the studies’ final follow-up. IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score. Dashes signify that information was not available in the article.
Gave qualitative grouping but did not report numbers.
Modified Coleman Methodology (MCMS) Results
| Study | Item 1 (10 pt) | Item 2 (5 pt) | Item 3 (5 pt) | Item 4 (10 pt) | Item 5 (15 pt) | Item 6 (5 pt) | Item 7 (5 pt) | Item 8 (5 pt) | Item 9 (10 pt) | Item 10 (15 pt) | Item 11 (15 pt) | Total MCMS Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpar and Bilsel[ | 4 | 3 | 3 | 5 | 10 | 0 | 5 | 0 | 0 | 6 | 10 | 46 |
| Alvarez-Diaz[ | 0 | 5 | 0 | 10 | 0 | 5 | 5 | 5 | 7 | 10 | 5 | 52 |
| Bizzini[ | 0 | 0 | 5 | 10 | 0 | 0 | 5 | 5 | 8 | 7 | 15 | 55 |
| Cassidy[ | 0 | 0 | 5 | 10 | 10 | 0 | 5 | 5 | 8 | 10 | 15 | 68 |
| Garofalo[ | 0 | 0 | 5 | 10 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 23 |
| Griffin[ | 0 | 3 | 0 | 5 | 0 | 5 | 0 | 0 | 5 | 10 | 10 | 38 |
| Haklar[ | 0 | 0 | 5 | 10 | 10 | 5 | 5 | 5 | 8 | 15 | 15 | 78 |
| Hetsroni[ | 0 | 0 | 5 | 10 | 0 | 5 | 5 | 5 | 8 | 10 | 15 | 63 |
| Krych[ | 4 | 3 | 3 | 5 | 0 | 0 | 3 | 3 | 8 | 10 | 15 | 54 |
| Maruyama[ | 0 | 0 | 5 | 10 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 20 |
| Marzo[ | 0 | 0 | 5 | 10 | 0 | 5 | 5 | 3 | 0 | 0 | 0 | 28 |
| Nakayama[ | 4 | 0 | 5 | 10 | 0 | 0 | 3 | 5 | 7 | 15 | 15 | 64 |
| Pabian[ | 0 | 0 | 5 | 10 | 0 | 5 | 0 | 5 | 10 | 12 | 5 | 52 |
| Papachristou[ | 0 | 3 | 0 | 5 | 10 | 0 | 3 | 5 | 5 | 10 | 15 | 56 |
| Park[ | 0 | 0 | 5 | 10 | 0 | 5 | 5 | 5 | 2 | 3 | 0 | 35 |
| Pujol[ | 0 | 3 | 0 | 10 | 0 | 5 | 3 | 3 | 8 | 10 | 15 | 57 |
| Sallé de Chou group 129 | 0 | 0 | 0 | 5 | 0 | 0 | 3 | 3 | 8 | 12 | 5 | 36 |
| Sallé de Chou group 229 | 0 | 5 | 5 | 5 | 0 | 0 | 3 | 3 | 8 | 12 | 5 | 46 |
| Sonnery-Cottet[ | 0 | 0 | 5 | 10 | 0 | 5 | 3 | 0 | 0 | 0 | 0 | 23 |
| Stein[ | 0 | 0 | 5 | 10 | 0 | 5 | 5 | 5 | 7 | 12 | 15 | 64 |
| Stein[ | 4 | 5 | 0 | 10 | 0 | 5 | 3 | 5 | 10 | 15 | 5 | 62 |
| Vanderhave[ | 0 | 0 | 5 | 10 | 0 | 5 | 3 | 3 | 7 | 12 | 5 | 50 |
| Mean | 0.73 | 1.36 | 3.45 | 8.64 | 1.82 | 2.73 | 3.64 | 3.55 | 5.64 | 8.68 | 8.41 | 48.64 |
| SD | ± 1.58 | ± 1.94 | ± 2.24 | ± 2.28 | ± 3.95 | ± 2.55 | ± 1.53 | ± 1.92 | ± 3.54 | ± 5.03 | ± 6.25 | ± 15.95 |
Item 1 = study size; item 2 = mean follow-up; item 3 = percentage of patients with follow-up; item 4 = number of different treatment procedures included; item 5 = type of study; item 6 = diagnostic certainty; item 7 = description of surgical procedure given; item 8 = description of postoperative rehabilitation; item 9 = outcome criteria; item 10 = procedures for assessing clinical outcomes; item 11 = description of patient selection process.
Full Search Using EMBASE, PubMed, and Cochrane Databases
| EMBASE | PubMed |
| 1. ‘menisc* repair’ | 1. Menisc* repair |
| 2. ‘menisc* repair’: ti,ab | 2. Meniscus |
| 3. ‘meniscus’ | 3. OR/1-2 |
| 4. ‘meniscus’: ti, ab | 4. “Knee” [Mesh Terms] |
| 5. OR/1-4 | 5. Knee* |
| 6. Knee/exp | 6. “Knee Joint” [Mesh Terms] |
| 7. Knee*:ti,ab | 7. Femorotibia* |
| 8. ‘Knee joint’/exp | 8. OR/4-7 |
| 9. Femorotibia*:ti,ab | 9. 3 AND 8 |
| 10. OR/6-9 | 10. Repair [Mesh Terms] |
| 11. 5 AND 10 | 11. Repair* |
| 12. Repair/exp | 12. Surgery [Mesh Terms] |
| 13. Repair*: ti,ab | 13. Surger* |
| 14. Surgery/exp | 14. Rehabilitation [Mesh Terms] |
| 15. Surger*: ti,ab | 15. Rehabilitation* |
| 16. Rehabilitation/exp | 16. “Return to” |
| 17. Rehabilitation*: ti,ab | 17. “Objective protocol*” |
| 18. ‘Return to’ | 18. OR/10-17 |
| 19. ‘Return to’:ti,ab | 19. 9 AND 18 |
| 20. ‘Objective protocol*’ | 20. Randomized Controlled Trial [Publication Type] |
| 21. ‘Objective protocol*’: ti,ab | 21. Randomized controlled trial |
| 22. OR/12-21 | 22. Controlled clinical trial [Publication Type] |
| 23. 11 AND 22 | 23. Double blind method |
| 24. (random* OR placebo*):ti,ab | 24. Single blind method |
| 25. ((singl* OR doubl* OR tripl*) AND (blind* OR mask*)) :ti,ab | 25. Clinical trial [Publication Type] |
| 26. Controlled clinical trial*:ti,ab | 26. Clinical trial |
| 27. Controlled clinical trial [controlled clinical trial]/lim | 27. (singl* OR doubl* OR tripl*) AND (mask* OR blind*) |
| 28. Randomized controlled trial [randomized controlled trial]/lim | 28. Placebo* |
| 29. ‘Comparative study’/exp | 29. Random* |
| 30. Comparative study: ti,ab | 30. Research design [Mesh Terms] |
| 31. Case series: ti,ab | 31. Comparative study [Publication Type] |
| 32. ‘Case series’/exp | 32. Comparative study |
| 33. ‘Prospective studies’/exp | 33. Evaluation studies [Publication Type] |
| 34. Prospective studies: ti,ab | 34. Evaluation study |
| 35. Placebo* | 35. Follow-up studies |
| 36. OR/24-35 | 36. Follow-up study |
| 37. 23 AND 36 | 37. Prospective studies |
| 38. ACL | 38. Prospective study |
| 39. anterior cruciate ligament | 39. Control* |
| 40. ‘anterior cruciate ligament’:ti,ab | 40. Prospectiv* |
| 41. (meniscectomy) NOT ‘repair’:ti,ab | 41. Case studies |
| 42. Reconstruction | 42. Case study |
| 43. Discoid | 43. OR/20-42 |
| 44. Transplant* | 44. 19 AND 43 |
| 45. ‘Systematic review‘:ti,ab | 45. English[language] |
| 46. revision | 46. 44 AND 45 |
| 47. OR/38-46 | 47. (“animals” [Mesh] NOT “humans” [Mesh]) |
| 48. 37 NOT 47 | 48. ACL |
| Total results: 321 | 49. anterior cruciate ligament |
| 50. anterior cruciate ligament[Title/Abstract] | |
| 51. (meniscectomy) NOT repair[Title/Abstract] | |
| 52. Reconstruction | |
| PubMed search: 1082 | |
| Cochrane | Cochrane |
| 1. Menisc* repair | 14. OR/9-13 |
| 2. meniscus | 15. 8 AND 14 |
| 3. OR/1-2 | 16. ACL |
| 4. Knee | 17. anterior cruciate ligament |
| 5. ‘Knee joint’ | 18. (meniscectomy) NOT ‘repair’ |
| 6. Femorotibia* | 19. Reconstruction |
| 7. OR/4-6 | 20. Discoid |
| 8. 3 AND 7 | 21. Transplant* |
| 9. Repair* | 22. ‘Systematic review’ |
| 10. Surger* | 23. revision |
| 11. Rehabilitation* | 24. OR/16-23 |
| 12. ‘Return to’ | 25. 15 NOT 24 |
| 13. ‘Objective protocol*’ | 81 articles in trials |